Carcinoembryonic antigen-related cell adhesion molecule 1: A link between insulin and lipid metabolism

Diabetes

Volumn 57, Issue 9, 2008, Pages 2296-2303

  Deangelis, Anthony M ^a   Heinrich, Garrett ^a   Dai, Tong ^a   Bowman, Thomas A ^a   Patel, Payal R ^a   Lee, Sang Jun ^a   Hong, Eun Gyoung ^b   Jung, Dae Young ^b   Assmann, Anke ^c   Kulkarni, Rohit N ^c   Kim, Jason K ^b   Najjar, Sonia M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; FATTY ACID; GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL; CARCINOEMBRYONIC ANTIGEN; CEACAM1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GENE MUTATION; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BODY WEIGHT; CELL CULTURE; DOMINANT GENE; GENETICS; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; LIVER; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BODY WEIGHT; CARCINOEMBRYONIC ANTIGEN; CELLS, CULTURED; GENES, DOMINANT; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 52749093917     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0379     Document Type: Article

References (37)

1. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential. Endocrinol Rev 19:608-624, 1998
2. Shillabeer G, Hornford J, Forden JM, Wong NC, Russell JC, Lau DC: Fatty acid synthase and adipsin mRNA levels in obese and lean JCR:LA-cp rats: effect of diet. J Lipid Res 33:31-39, 1992
3. Assimacopoulos-Jeannet F, Brichard S, Rencurel F, Cusin I, Jeanrenaud B: In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues. Metabolism, 44:228-233, 1995
4. Rabkin R, Ryan MP, Duckworth WC: The renal metabollism of insulin. Diabetologia 27:351-357, 1984
5. Formisano P, Najjar SM, Gross CN, Philippe N, Oriente F, Kern BCL, Accili D, Gorden P: Receptor-mediated internalization of insulin: potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 270:24073-24077, 1995
6. Li Calzi S, Choice CV, Najjar SM: Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms. Am J Physiol 273:E801-E808, 1997
7. Najjar SM, Choice CV, Soni P, Whitman CM, Poy MN: Effect of pp120 on receptor-mediated insulin endocytosis is regulated by the juxtamembrane domain of the insulin receptor. J Biol Chem 273:12923-12928, 1998
8. Poy MN, Yang Y, Rezaei K, Fernstrom MA, Lee AD, Kido Y, Erickson SK, Najjar SM: CEACAM1 regulates insulin clearance in liver. Nat Genet 30:270-276, 2002
9. Dubois MJ, Bergeron S, Kim HJ, Dombrowski L, Perreault M, Fournes B, Faure R, Olivier M, Beauchemin N, Shulman GI, Siminovitch KA, Kim JK, Marette A: The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med 12:549-556, 2006
10. Park SY, Cho YR, Kim HJ, Hong EG, Higashimori T, Lee SJ, Goldberg IJ,
11. Shulman GI, Najjar SM, Kim JK: Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. Am J Physiol Endocrinol Metab 291:E517-E524, 2006
12. Leung N, Turbide C, Olson M, Marcus V, Jothy S, Beauchemin N: Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene 25:5527-5536, 2006
13. Dai T, Abou-Rjaily GA, Al-Share' QY, Yang Y, Fernstrom MA, DeAngelis AM, Lee AD, Sweetman L, Amato A, Pasquali M, Lopaschuk GD, Erickson SK, Najjar SM: Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. J Biol Chem 279:45155-45161, 2004
14. Powers AC, Efrat S, Mojsov S, Spector D, Habener JF, Hanahan D: Proglucagon processing similar to normal islets in pancreatic a-like cell line derived from transgenic mouse tumor. Diabetes 39:406-414, 1990
15. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K: Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132, 1990
16. Najjar SM, Philippe N, Suzuki Y, Ignacio GA, Formisano P, Accili D, Taylor SI: Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry 34:9341-9349, 1995
17. Sadekova S, Lamarche-Vane N, Li X, Beauchemin N: The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases. Mol Biol Cell 11:65-77, 2000
18. Kitamura T, Kido Y, Nef S, Merenmies J, Parada LF, Accili D: Preserved pancreatic beta cell function in mice lacking the insulin receptor-related receptor. Mol Cell Biol 21:5624-5630, 2001
19. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR: Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339, 1999
20. Josefsen K, Stenvang JP, Kindmark H, Berggren PO, Horn T, Kjaer T, Buschard K: Fluorescence-activated cell sorted rat islet cells and studies of the insulin secretory process. J Endocrinol 149:145-154, 1996
21. Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF, Li H, Elmquist JK, Kennedy RT, Kulkarni RN: Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 117:2860-2868, 2007
22. DeFronzo RA: Lilly lecture 1987. The triumvirate: p-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687, 1988
23. Chen X, Iqbal N, Boden G: The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103:365-372,1999
24. Horton JD, Goldstein JL, Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131, 2002
25. Najjar SM, Yang Y, Fernstrom MA, Lee SJ, Deangelis AM, Rjaily GA, Al-Share QY, Dai T, Miller TA, Ratnam S, Ruch RJ, Smith S, Lin SH, Beauchemin N, Oyarce AM: Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2:43-53, 2005
26. Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montminy MR, White MF: Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 109:1193-1201, 2002
27. Suzuki R, Tobe K, Terauchi Y, Komeda K, Kubota N, Eto K, Yamauchi T, Azuma K, Kaneto H, Taguchi T, Koga T, German MS, Watada H, Kawamori R, Wright CV, Kajimoto Y, Kimura S, Nagai R, Kadowaki T: Pdx1 expression in Irs2-deficient mouse beta-cells is regulated in a strain-dependent manner. J Biol Chem 278:43691-43698, 2003
28. Accili D, Perrotti N, Rees JR, Taylor SI: Tissue distribution and subcellular localization of an endogenous substrate (pp120) for the insulin receptor- associated tyrosine kinase. Endocrinology 119:1274-1280, 1986
29. Elam MB, Wilcox HG, Cagen LM, Deng X, Raghow R, Kumar P, Heimberg M, Russell JC: Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J Lipid Res 42:2039-2048, 2001
30. Ginsberg HN, Zhang YL, Hernandez-Ono A: Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36:232-240, 2005
31. Matikainen N, Manttari S, Westerbacka J, Vehkavaara S, Lundbom N, Yki-Jarvinen H, Taskinen MR: Postprandial lipemia associates with liver fat content. J Clin Endocrinol Metab 92:3052-3059, 2007
32. Vine DF, Takechi R, Russell JC, Proctor SD: Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis 190:282-290, 2007
33. Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, Chen M, Stannard B, Dietz KR, Le Roith D, Reitman ML: Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145:3258-3264, 2004
34. Colombo C, Haluzik M, Cutson JJ, Dietz KR, Marcus-Samuels B, Vinson C, Gavrilova O, Reitman ML: Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice: role of triglyceride clearance. J Biol Chem 278:3992-3999, 2003
35. Clee SM, Attie AD: The genetic landscape of type 2 diabetes in mice. EndocrRev 28:48-83, 2007
36. Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Aleman JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR: Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 7:125-134, 2008
37. Han E, Phan D, Lo P, Poy MN, Behringer R, Najjar SM, Lin S-H: Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. Biochem J 355:417-423, 2001